Market Research Logo

Alopecia - Pipeline Review, H2 2015

Alopecia - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Alopecia - Pipeline Review, H2 2015’, provides an overview of the Alopecia’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Alopecia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Alopecia and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Alopecia
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Alopecia and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Alopecia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Alopecia pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
Reasons to buy
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Alopecia
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Alopecia pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Introduction
Global Markets Direct Report Coverage
Alopecia Overview
Therapeutics Development
Pipeline Products for Alopecia - Overview
Pipeline Products for Alopecia - Comparative Analysis
Alopecia - Therapeutics under Development by Companies
Alopecia - Therapeutics under Investigation by Universities/Institutes
Alopecia - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Unknown Stage Products
Alopecia - Products under Development by Companies
Alopecia - Products under Investigation by Universities/Institutes
Alopecia - Companies Involved in Therapeutics Development
Allergan Plc
AndroScience Corporation
Berg, LLC
Bristol-Myers Squibb Company
Dong-A Socio Group
Follicum AB
Histogen, Inc.
Hyundai Pharmaceutical Co., Ltd.
Kuhnil Pharmaceutical Co., Ltd.
Kythera Biopharmaceuticals, Inc.
Lee's Pharmaceutical Holdings Limited
Panacea Biotec Limited
Polichem S.A.
R-Tech Ueno, Ltd.
RepliCel Life Sciences, Inc.
RestorGenex Corporation
RXi Pharmaceuticals Corporation
SWITCH Biotech LLC
Taisho Pharmaceutical Co., Ltd.
Tigo GmbH
Valeant Pharmaceuticals International, Inc.
Vida Therapeutics Inc.
Alopecia - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
abatacept - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Antibodies to Inhibit Heparanase for Cancer - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ASCJ-9 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
bimatoprost - Drug Profile
Product Description
Mechanism of Action
R&D Progress
BMD-2341 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
BRM-421 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
calcitriol - Drug Profile
Product Description
Mechanism of Action
R&D Progress
CB-0301 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
DHL-HisZnNa - Drug Profile
Product Description
Mechanism of Action
R&D Progress
diphencyprone - Drug Profile
Product Description
Mechanism of Action
R&D Progress
finasteride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
finasteride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
FOL-005 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Hair Stimulating Complex (HSC) - Drug Profile
Product Description
Mechanism of Action
R&D Progress
HTB-005 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
interferon beta-1b - Drug Profile
Product Description
Mechanism of Action
R&D Progress
KI-1104 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
KI-1105 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
minoxidil - Drug Profile
Product Description
Mechanism of Action
R&D Progress
OLX-104 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Peptide for Alopecia - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PRD-006 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
RCH-01 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Recombinant Proteins to Antagonize IFN-Gamma Receptor for Alopecia Areata and Graft Arteriosclerosis - Drug Profile
Product Description
Mechanism of Action
R&D Progress
RES-440 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
RK-023 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
setipiprant - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SM-04554 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Androgenic Alopecia - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit ALK5 for Alopecia - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Dermatological Disorders - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Activate P2Y5 Receptor for Alopecia - Drug Profile
Product Description
Mechanism of Action
R&D Progress
VTI-1000 Series - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ZK-003 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Alopecia - Recent Pipeline Updates
Alopecia - Dormant Projects
Alopecia - Discontinued Products
Alopecia - Product Development Milestones
Featured News & Press Releases
Oct 26, 2012: Glaucoma Drug Bimatoprost May Be Effective In Treating Alopecia, New Research In FASEB Journal Shows
Jul 23, 2012: Berg Pharma Launches Clinical Trial On BPM 31543 For Prevention Of Chemotherapy-induced Alopecia
Jan 24, 2011: R-Tech Ueno Completes Phase IIa Clinical Study Of RK-023 To Treat Androgenetic Alopecia
Oct 06, 2010: Cosmo Reports Positive Results In Alopecia Study With CB-03-01
Oct 06, 2009: R-Tech Ueno Initiates Early Phase II Clinical Trial For RK-023
Jul 16, 2009: Notification Of The Completion Of Phase I Clinical Study Of RK-023
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Alopecia, H2 2015
Number of Products under Development for Alopecia - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Development, H2 2015
Comparative Analysis by Unknown Stage Development, H2 2015
Products under Development by Companies, H2 2015
Products under Development by Companies, H2 2015 (Contd..1)
Products under Investigation by Universities/Institutes, H2 2015
Alopecia - Pipeline by Allergan Plc, H2 2015
Alopecia - Pipeline by AndroScience Corporation, H2 2015
Alopecia - Pipeline by Berg, LLC, H2 2015
Alopecia - Pipeline by Bristol-Myers Squibb Company, H2 2015
Alopecia - Pipeline by Dong-A Socio Group, H2 2015
Alopecia - Pipeline by Follicum AB, H2 2015
Alopecia - Pipeline by Histogen, Inc., H2 2015
Alopecia - Pipeline by Hyundai Pharmaceutical Co., Ltd., H2 2015
Alopecia - Pipeline by Kuhnil Pharmaceutical Co., Ltd., H2 2015
Alopecia - Pipeline by Kythera Biopharmaceuticals, Inc., H2 2015
Alopecia - Pipeline by Lee's Pharmaceutical Holdings Limited, H2 2015
Alopecia - Pipeline by Panacea Biotec Limited, H2 2015
Alopecia - Pipeline by Polichem S.A., H2 2015
Alopecia - Pipeline by R-Tech Ueno, Ltd., H2 2015
Alopecia - Pipeline by RepliCel Life Sciences, Inc., H2 2015
Alopecia - Pipeline by RestorGenex Corporation, H2 2015
Alopecia - Pipeline by RXi Pharmaceuticals Corporation, H2 2015
Alopecia - Pipeline by SWITCH Biotech LLC, H2 2015
Alopecia - Pipeline by Taisho Pharmaceutical Co., Ltd., H2 2015
Alopecia - Pipeline by Tigo GmbH, H2 2015
Alopecia - Pipeline by Valeant Pharmaceuticals International, Inc., H2 2015
Alopecia - Pipeline by Vida Therapeutics Inc., H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Stage and Target, H2 2015
Number of Products by Stage and Mechanism of Action, H2 2015
Number of Products by Stage and Route of Administration, H2 2015
Number of Products by Stage and Molecule Type, H2 2015
Alopecia Therapeutics - Recent Pipeline Updates, H2 2015
Alopecia - Dormant Projects, H2 2015
Alopecia - Dormant Projects (Contd..1), H2 2015
Alopecia - Dormant Projects (Contd..2), H2 2015
Alopecia - Discontinued Products, H2 2015
List of Figures
Number of Products under Development for Alopecia, H2 2015
Number of Products under Development for Alopecia - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Products, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Top 10 Targets, H2 2015
Number of Products by Stage and Top 10 Targets, H2 2015
Number of Products by Top 10 Mechanism of Actions, H2 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015
Number of Products by Top 10 Routes of Administration, H2 2015
Number of Products by Stage and Top 10 Routes of Administration, H2 2015
Number of Products by Top 10 Molecule Types, H2 2015
Number of Products by Stage and Top 10 Molecule Types, H2 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report